The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01741090|
Recruitment Status : Unknown
Verified December 2012 by Moon Young Kim, Yonsei University.
Recruitment status was: Recruiting
First Posted : December 4, 2012
Last Update Posted : December 10, 2012
Information provided by (Responsible Party):
Moon Young Kim, Yonsei University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||June 2013|
|Estimated Study Completion Date :||August 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY, Park HJ, Park SY, Kim BR, Kim JW, Soo Kim H, Kwon SO, Choi EH, Kim YM. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014 Jan;34(1):33-41. doi: 10.1111/liv.12218. Epub 2013 Jun 19.